PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • Visit this company: www.aethlonmedical.com SAN DIEGO - February, 2012 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, reported today that the administration of Hemopurifier?? therapy during the first three days of standard of care pegin
http://www.w3.org/ns/prov#wasQuotedFrom
  • investorideas.com